These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1554241)

  • 1. Gene expression of protein kinase C subtypes in normal and psoriatic epidermis.
    Wevers A; Wirnitzer U; Schaarschmidt H; Hegemann L; Mahrle G
    Arch Dermatol Res; 1992; 284(1):5-7. PubMed ID: 1554241
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunohistological identification of protein kinase C isozymes in normal and psoriatic epidermis.
    Inohara S; Tatsumi Y; Tanaka Y; Tateishi H; Sagami S
    Arch Dermatol Res; 1988; 280(7):454-5. PubMed ID: 3207371
    [No Abstract]   [Full Text] [Related]  

  • 3. Decreased protein kinase C activity in psoriatic versus normal epidermis.
    Horn F; Marks F; Fisher GJ; Marcelo CL; Voorhees JJ
    J Invest Dermatol; 1987 Feb; 88(2):220-2. PubMed ID: 3805758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of protein kinase C isoenzymes in normal and psoriatic adult human skin: reduced expression of protein kinase C-beta II in psoriasis.
    Fisher GJ; Tavakkol A; Leach K; Burns D; Basta P; Loomis C; Griffiths CE; Cooper KD; Reynolds NJ; Elder JT
    J Invest Dermatol; 1993 Oct; 101(4):553-9. PubMed ID: 8409523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased phospholipase C-catalyzed hydrolysis of phosphatidylinositol-4,5-bisphosphate and 1,2-sn-diacylglycerol content in psoriatic involved compared to uninvolved and normal epidermis.
    Fisher GJ; Talwar HS; Baldassare JJ; Henderson PA; Voorhees JJ
    J Invest Dermatol; 1990 Oct; 95(4):428-35. PubMed ID: 2170539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular regulated kinase and c-Jun N-terminal kinase are activated in psoriatic involved epidermis.
    Takahashi H; Ibe M; Nakamura S; Ishida-Yamamoto A; Hashimoto Y; Iizuka H
    J Dermatol Sci; 2002 Nov; 30(2):94-9. PubMed ID: 12413764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased phosphatidylinositol kinase activity in psoriatic epidermis.
    Pike MC; Lee CS; Elder JT; Voorhees JJ; Fisher GJ
    J Invest Dermatol; 1989 Jun; 92(6):791-7. PubMed ID: 2542414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDK5 regulates cell-cell and cell-matrix adhesion in human keratinocytes.
    Nakano N; Nakao A; Ishidoh K; Tsuboi R; Kominami E; Okumura K; Ogawa H
    Br J Dermatol; 2005 Jul; 153(1):37-45. PubMed ID: 16029324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of transglutaminase 1 mRNA in normal and psoriatic epidermis by non-radioactive in situ hybridization.
    Nonomura K; Yamanishi K; Hosokawa Y; Doi H; Hirano J; Fukushima S; Yasuno H
    Br J Dermatol; 1993 Jan; 128(1):23-8. PubMed ID: 7678985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue plasminogen activator in psoriasis.
    Jensen PJ; Baird J; Belin D; Vassalli JD; Busso N; Gubler P; Lazarus GS
    J Invest Dermatol; 1990 Nov; 95(5 Suppl):13S-14S. PubMed ID: 16788619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane-bound phospholipase C activity in normal and psoriatic epidermis.
    Bergers M; van de Kerkhof PC; Happle R; Mier PD
    Acta Derm Venereol; 1990; 70(1):57-9. PubMed ID: 1967875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Casein kinase II activity in psoriatic epidermis.
    Mitev VI; Miteva L; Dourmishev A
    Arch Dermatol Res; 1992; 284(2):111-3. PubMed ID: 1610211
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel histone-stimulated protein kinase in normal and psoriatic epidermis.
    Takematsu H; Fisher GJ; Voorhees JJ
    J Invest Dermatol; 1989 Mar; 92(3):385-90. PubMed ID: 2918242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-localization of COX-2, CYP4F8, and mPGES-1 in epidermis with prominent expression of CYP4F8 mRNA in psoriatic lesions.
    Stark K; Törmä H; Oliw EH
    Prostaglandins Other Lipid Mediat; 2006 Mar; 79(1-2):114-25. PubMed ID: 16516815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aryl hydrocarbon hydroxylase, epoxide hydrolase, and benzo[a]-pyrene metabolism in human epidermis: comparative studies in normal subjects and patients with psoriasis.
    Bickers DR; Mukhtar H; Dutta-Choudhury T; Marcelo CL; Voorhees JJ
    J Invest Dermatol; 1984 Jul; 83(1):51-6. PubMed ID: 6330212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased protein kinase C activity in fibroblast membranes from psoriatic patients.
    Nagao S; Seishima M; Mori S; Nozawa Y
    J Invest Dermatol; 1988 Mar; 90(3):406-8. PubMed ID: 3346560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of a growth-related cytosol protein kinase in the pathogenesis of psoriasis].
    Miteva L; Mitev V; Durmishev A
    Eksp Med Morfol; 1994; 32(3-4):19-26. PubMed ID: 8857029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspase 9 is decreased in psoriatic epidermis.
    Oztaş P; Lortlar N; Oztaş MO; Omeroglu S; Gürer MA; Alli N
    Acta Histochem; 2006; 108(6):497-9. PubMed ID: 17034836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of aryl hydrocarbon hydroxylase in psoriatic skin.
    Chapman PH; Rawlins MD; Shuster S
    Lancet; 1979 Feb; 1(8111):297-8. PubMed ID: 84948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The ornithine decarboxylase activity of the epidermis in psoriasis as a biochemical index of the hyperproliferative process].
    Kagramanova AT; Tishchenko LD; Berezov TT
    Biull Eksp Biol Med; 1993 Jun; 115(6):618-20. PubMed ID: 8374143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.